In the second quarter of 2006, the FDA approved a new drug called Vivitrol to help treat alcoholism. More recently, it has been FDA-approved for the prevention of opioid dependence, following opioid detoxification.

Vivitrol is the first and only injectable version of naltrexone, a powerful weapon against alcohol and opiate dependence. It is intended for use with people who are able to abstain from substance abuse in an outpatient setting. It is also indicated for use in combination with psychosocial support, such as counseling or group therapy.

At the Assisted Recovery Centers of Georgia, we utilize naltrexone (Revia) to reduce cravings, which has been highly effective for long-term recovery. Unlike deterrent medications that make you ill, naltrexone simply and safely eliminates the “high” or “buzz” associated with alcohol and drug use. In addition, it significantly lessens the physical “need” to use. Coupled with a personalized cognitive/behavioral program, naltrexone allows the freedom to focus on the emotional and mental facets of addiction.

It has been our experience at the Assisted Recovery Centers of Georgia that the majority of those who have relapsed after our treatment program were people who for one reason or another could not follow their daily regimen of naltrexone in the prescribed dosage.

The time-released formula works the same as the oral naltrexone and is simply another, more powerful safeguard against relapse.

With Vivitrol, individuals who have difficulty maintaining their daily dose of naltrexone now have the option of receiving a monthly injection of Vivitrol. The time-released formula works the same as the oral naltrexone and is simply another, more powerful safeguard against relapse.